Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Arch Pharm Res ; 44(2): 133-145, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33550564

ABSTRACT

The high incidence of obesity has increased the need to discover new therapeutic targets to combat obesity and obesity-related metabolic diseases. Obesity is defined as an abnormal accumulation of adipose tissue, which is one of the major metabolic organs that regulate energy homeostasis. However, there are currently no approved anti-obesity therapeutics that directly target adipose tissue metabolism. With recent advances in the understanding of adipose tissue biology, molecular mechanisms involved in brown adipose tissue expansion and metabolic activation have been investigated as potential therapeutic targets to increase energy expenditure. This review focuses on G-protein coupled receptors (GPCRs) as they are the most successful class of druggable targets in human diseases and have an important role in regulating adipose tissue metabolism. We summarize recent findings on the major GPCR classes that regulate thermogenesis and mitochondrial metabolism in adipose tissue. Improved understanding of GPCR signaling pathways that regulate these processes could facilitate the development of novel pharmacological approaches to treat obesity and related metabolic disorders.


Subject(s)
Adipose Tissue, Brown/metabolism , Energy Metabolism/physiology , Metabolic Diseases/drug therapy , Metabolic Diseases/metabolism , Receptors, G-Protein-Coupled/metabolism , Adipose Tissue/drug effects , Adipose Tissue/metabolism , Adipose Tissue/pathology , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/pathology , Animals , Energy Metabolism/drug effects , Humans , Obesity/drug therapy , Obesity/metabolism , Phosphoserine/administration & dosage , Phosphoserine/analogs & derivatives , Pyrazoles/administration & dosage , Pyridines/administration & dosage , Receptors, G-Protein-Coupled/agonists , Receptors, G-Protein-Coupled/antagonists & inhibitors , Sphingosine 1 Phosphate Receptor Modulators/administration & dosage , Thermogenesis/drug effects , Thermogenesis/physiology
2.
Biomolecules ; 10(10)2020 09 30.
Article in English | MEDLINE | ID: mdl-33008006

ABSTRACT

Soy isoflavones are bioactive phytoestrogens with known health benefits. Soybean embryo extract (SEE) has been consumed as a source of isoflavones, mainly daidzein, glycitein, and genistein. While previous studies have reported the anti-obesity effects of SEE, this study investigates their molecular mechanisms and the synergistic effects of co-treatment with SEE and enzymatically modified isoquercitrin (EMIQ). SEE upregulated genes involved in lipolysis and brown adipocyte markers and increased mitochondrial content in differentiated C3H10T1/2 adipocytes in vitro. Next, we use a high-fat diet-induced obesity mouse model to determine the anti-obesity effect of SEE. Two weeks of single or combined treatment with SEE and EMIQ significantly reduced body weight gain and improved glucose tolerance. Mechanistically, SEE treatment increased mitochondrial content and upregulated genes involved in lipolysis in adipose tissue through the cAMP/PKA-dependent signaling pathway. These effects required a cytosolic lipase adipose triglyceride lipase (ATGL) expression, confirmed by an adipocyte-specific ATGL knockout mouse study. Collectively, this study demonstrates that SEE exerts anti-obesity effects through the activation of adipose tissue metabolism and exhibits a synergistic effect of co-treatment with EMIQ. These results improve our understanding of the mechanisms underlying the anti-obesity effects of SEE related to adipose tissue metabolism.


Subject(s)
Glycine max/chemistry , Lipolysis/drug effects , Obesity/drug therapy , Quercetin/analogs & derivatives , Adipocytes/drug effects , Adipose Tissue/drug effects , Adipose Tissue/pathology , Animals , Cell Differentiation/drug effects , Diet, High-Fat/adverse effects , Genistein/chemistry , Genistein/pharmacology , Humans , Isoflavones/chemistry , Isoflavones/pharmacology , Mice , Obesity/etiology , Obesity/genetics , Obesity/pathology , Phytoestrogens/chemistry , Phytoestrogens/pharmacology , Plant Extracts/chemistry , Plant Extracts/pharmacology , Quercetin/chemistry , Quercetin/pharmacology , Seeds/chemistry
3.
Sci Rep ; 7(1): 7159, 2017 08 02.
Article in English | MEDLINE | ID: mdl-28769076

ABSTRACT

We investigated the role of connexin 43 (Cx43) in maintaining the integrity of mitochondria in brown adipose tissue (BAT). The functional effects of Cx43 were evaluated using inducible, adipocyte-specific Cx43 knockout in mice (Gja1 adipoq KO) and by overexpression and knockdown of Cx43 in cultured adipocytes. Mitochondrial morphology was evaluated by electron microscopy and mitochondrial function and autophagy were assessed by immunoblotting, immunohistochemistry, and qPCR. The metabolic effects of adipocyte-specific knockout of Cx43 were assessed during cold stress and following high fat diet feeding. Cx43 expression was higher in BAT compared to white adipose tissue. Treatment with the ß3-adrenergic receptor agonist CL316,243 increased Cx43 expression and mitochondrial localization. Gja1 adipoq KO mice reduced mitochondrial density and increased the presence of damaged mitochondria in BAT. Moreover, metabolic activation with CL316,243 further reduced mitochondrial integrity and upregulated autophagy in the BAT of Gja1 adipoq KO mice. Inhibition of Cx43 in cultured adipocytes increased the generation of reactive oxygen species and induction of autophagy during ß-adrenergic stimulation. Gja1 adipoq KO mice were cold intolerant, expended less energy in response to ß3-adrenergic receptor activation, and were more insulin resistant after a high-fat diet challenge. Collectively, our data demonstrate that Cx43 is required for maintaining the mitochondrial integrity and metabolic activity of BAT.


Subject(s)
Adipose Tissue, Brown/metabolism , Connexin 43/metabolism , Mitochondria/metabolism , Adipocytes/metabolism , Animals , Connexin 43/genetics , Connexins/metabolism , Gene Knockdown Techniques , Immunohistochemistry , Male , Mice , Mice, Knockout , Mitochondria/ultrastructure , Mitochondrial Proteins/metabolism , Oxidative Stress , Phenotype , Protein Transport
SELECTION OF CITATIONS
SEARCH DETAIL
...